Summary
Drugs ingested by a lactating mother would be expected to appear in human milk to some extent and be ingested by a breast-feeding infant. Drugs pass from maternal plasma into milk by passive diffusion and are distributed within the aqueous, protein and lipid phases of milk. Distribution into milk will be affected by physiochemical characteristics of the drug: acid-base characteristics, relative protein binding in plasma and milk, and lipid solubility, as well as milk composition.
The milk-to-plasma concentration ratio is the most commonly quoted index of drug distribution into human milk. However, calculation of the daily infant dose of drug ingested in milk, and from this the dose in milk relative to the maternal dose on a weight-adjusted basis, is a more relevant indicator of infant exposure to a drug. This is particularly true for drugs with a high volume of distribution, for which only a small proportion of the mother’s dose is contained within the plasma and available for distribution into milk.
A better indication of infant exposure to a drug is the steady-state plasma drug concentration in a breast-feeding infant, the major determinants of which are the dose rate (via milk) and the oral availability and clearance in the infant. Although in neonates the rate of absorption may be different from adults, there is little evidence that its extent is significantly different. Clearance, however, is impaired in very young infants, particularly if premature. The decreased clearance would result in a proportional increase in steady-state plasma concentrations in the breast-feeding infant. Consideration of the dose ingested in milk and the approximate clearance in infants of different ages allows estimation of likely steady-state plasma concentrations in breast-feeding infants.
From these considerations, recommendations regarding the safety of drugs during breastfeeding can be made. Drugs which are very toxic or have dose-independent toxicity should be considered separately. Recommendations regarding ‘social’ drugs such as nicotine, alcohol, caffeine and theobromine are particularly difficult, as doses are uncontrolled and vary variable.
Similar content being viewed by others
References
Allgen LG, Holmberg G, Persson B, Sorbo B. Biological fate of methenamine in man. Acta Obstetricia et Gynaecologica Scandinavica 58: 287–293, 1979
American Academy of Pediatrics. The transfer of drugs and other chemicals into human breast milk. Pediatrics 72(3): 375–383, 1983
Anderson HJ. Excretion of verapamil in human milk. European Journal of Clinical Pharmacology 25: 279–280, 1983
Anderson HJ, Bondesson U, Mattiasson I, Johansson BW. Verapamil and norverapamil in plasma and breast milk during breast feeding. European Journal of Clinical Pharmacology 31: 625–627, 1987
Ansell C, Moore A, Barrie H. Electrolyte and pH changes in human milk. Pediatric Research 11: 1177–1179, 1977
Aranda JV, Turman T. Methylxanthines in apnea of prematurity. Clinics in Perinatology 6: 87–108, 1979
Arant BS. Developmental patterns of renal functional maturation compared in the human neonate. Journal of Pediatrics 92: 705–711, 1978
Atkinson HC, Begg EJ. Drug protein binding in human milk. New Zealand Medical Journal 100: 251, 1987
Bader T, Newman K. Amitriptyline in human breast milk and the nursing infant’s serum. American Journal of Psychiatry 137: 855–856, 1980
Barnett DB, Hudson SA, McBurney A. Disopyramide and its nmonodesalkyl metabolite. British Journal of Clinical Pharmacology 14: 310–312, 1982
Bass JW, Crowley DM, Steele RW, Young FSH, Harden LB. Adverse effects of orally administered ampicillin. Journal of Pediatrics 82: 106–108, 1973
Baty JD, Breckenridge A, Lewis PJ, Orme M, Serlin MJ, et al. May mothers taking warfarin breast feed their infants. British Journal of Clinical Pharmacology 3: 969, 1976
Bauer J, Pape B, Zajicek J, Groshong T. Propranolol in human plasma and breast milk. American Journal of Cardiology 43: 860–862, 1979
Beeley L. Drugs and breast feeding. Clinics in Obstetrics and Gynaecology 8: 291–295, 1981
Bell RAF, Dale IM. Gold secretion in maternal milk. Arthritis and Rheumatism 19: 1374, 1976
Belton EM, Jones RV. Haemolytic anaemia due to nalidixic acid. Lancet 2: 691, 1965
Berlin CM. Excretion of methylxanthines in human milk. Seminars in Perinatology 5: 389–394, 1981
Berlin CM, Lee C. Isoniazid and acetylisoniazid disposition in human milk and plasma. Federal Proceedings 38: 426, 1979
Bernstine JB, Meyer AE, Bernstine RL. Maternal blood and breast milk estimation following the administration of chloral hydrate during the puerperium. Journal of Obstetrics and Gynaecology of the British Empire 63: 228–231, 1956
Bhaskar A, Schulze P, Acksteiner B, Laumas K. Quantitative analysis of norethindrone in milk using deuterated carrier and gas chromatography-mass spectrometry. Journal of Steroid Biochemistry 11: 1323–1328, 1979
Binckiewicz A, Robinson MJ, Senior B. Pseudo-Cushing syndrome caused by alcohol in breast milk. Journal of Pediatrics 93: 965–967, 1978
Bitzen PO, Gustafsson KG, Melander A, Wahlin-Boll E. Excretion of paracetamol in human breast milk. European Journal of Clinical Pharmacology 20: 123–125, 1981
Blacker KH, Weinstein BJ, Ellman GL. Mother’s milk and chlorpromazine. American Journal of Psychiatry 19: 178–179, 1962
Boreus LO, De Chateau P, Lindberg C, Nyberg L. Terbutaline in breast milk. British Journal of Clinical Pharmacology 13: 731–732, 1982
Boutroy MJ, Bianchette G, Dubruc C, Vert P, Morselli PL. To nurse when receiving acebutolol: is it dangerous for the neonate? European Journal of Clinical Pharmacology 30: 737–739, 1986
Brandt R. Passage of diazepam and desmethyldiazepam into breast milk. Arzneimittel-Forschung 26: 454–457, 1976
Brixen-Rasmussen L, Halgrener J, Jorgenson A. Amitriptyline and nortriptyline excretion in breast milk. Psychopharmacology 76: 94–95, 1982
Buchanan N. Drugs in lactation. New Ethicals 23: 43–54, 1986
Buchanan R, Eaton C, Keoff S, Kinkel A. The breast milk excretion of mefenamic acid. Therapeutic Research 10: 592–596, 1968
Butler NR, Goldstein H, Ross EM. Cigarette smoking in pregnancy: its influence on birthweight and perinatal mortality. British Medical Journal 2: 127–130, 1972
Cashore WJ, Stern L. Neonatal hypobilirubinaemia. Pediatrics Clinics of North America 29: 1191–1204, 1982
Chaikin P, Chasin M, Kennedy B, Silverman B. Suprofen concentrations in human breast milk. Journal of Clinical Pharmacology 23: 385–390, 1983
Chan V, Tse TF, Wong V. Transfer of digoxin across the placenta and into breast milk. British Journal of Obstetrics and Gynaecology 85: 605–609, 1978
Chicarrel FS, Eisner HJ. Metabolic and pharmacokinetic studies with fenbufen in man. Arzneimittel-Forschung 30(4A): 728–735, 1980
Cobo E. Effect of different doses of ethanol on the milk ejection reflex in lactating women. American Journal of Obstetrics and Gynecology 115: 817–821, 1973
Cooper D, Bode H, Nath B, Saxe V, Mallof F, et al. Methimazole pharmacology in man: studies using a newly developed radioimmunoassay for methimazole. Journal of Clinical Endocrinology and Metabolism 58: 473–479, 1984
Cruikshank DP, Varner MW, Pitkin RM. Breast milk magnesium and calcium concentrations following magnesium sulfate treatment. American Journal of Obstetrics and Gynecology 143: 685–688, 1982
Curry SH, Ridall D, Gordon SJ, Simpson P, Binns TB, et al. Disposition of glutethimide in man. Clinical Pharmacology and Therapeutics 12: 849–857, 1971
Davies DM (Ed). A textbook of adverse drug reactions, 3rd ed., pp. 586–587, Oxford University Press, Oxford, 1985
Devlin RG, Duchin KL, Fleiss PM. Nadalol in human serum and breast milk. British Journal of Clinical Pharmacology 12: 393–396, 1981
Devlin RG, Fleiss PM. Captopril in human blood and breast milk. Journal of Clinical Pharmacology 21: 110–113, 1981
Diaz S, Herreros C, Juez G, Casado ME, Salvatierra AM, et al. Fertility regulation in nursing women. Contraception 32: 53–74, 1985
Dietrich J, Krause AN, Reidenberg M, Drayer DE, Auld PAM. Alterations in state in apneic pre-term infants receiving theophylline. Clinical Pharmacology and Therapeutic 24: 474–478, 1978
Dobbing J. The later development of the brain and its vulnerability. In Davis & Dobbing (Eds) Scientific foundations of paediatrics, 2nd ed., pp. 744–758, William Heinemann, London. 1981
Dowdell PM. Alcohol and pregnancy: a review of the literature 1968-1980. Nursing Times 77: 1826–1831, 1981
Dresse A, Lambotte R, Dubois M, Delapierre D, Kramp R. Transmammary passage of cefoxitin: additional results. Journal of Clinical Pharmacology 23: 438–440, 1983
Dutton GJ. Developmental aspects of drug conjugations, with special reference to glucuronidation. Annual Review of Pharmacology and Toxicology 18: 17–35, 1978
Ecobichon DJ, Stephens DS. Perinatal development of human blood esterases. Clinical Pharmacology and Therapeutics 14: 41–47, 1972
Editorial. Solvents and the central nervous system. Lancet 2: 565–566, 1981
Edstein MD, Veenendaal JR, Newman K, Hyslop R. Excretion of chloroquine, dapsone, and pyrimethamine in human milk. British Journal of Clinical Pharmacology 22: 733–735, 1986
Egan PC, Costanza ME, Dodion P, Egorin MJ, Bachur NR. Doxorubicin and cisplatin excretion into human milk. Cancer Treatment Reports 69: 1387–1389, 1985
Ekstrand J, Boreus LO, De Chateau P. No evidence of transfer of fluoride from plasma to breast milk. British Medical Journal 283: 761–762, 1981
Ekstrand J, Spak CJ, Falch J, Afseth J, Ulvestad H. Distribution of fluoride to human breast milk. Caries Research 18: 93–95, 1984
Erickson S, Oppenheim G, Smith G. Metronidazole in breast milk. Obstetrics and Gynaecology 57: 48–50, 1981
Eriksson G, Swahn CG. Concentrations of baclofen in serum and breast milk from a lactating woman. Scandinavian Journal of Clinical Laboratory Investigation 41: 185–187, 1981
Erkkola R, Kanto J. Diazepam and breast feeding. Lancet 1: 1235–1236, 1972
Erkkola R, Kanto J, Allonen H, Kleimola T, Mantyla R. Excretion of methylergometrine (methylergonovine) into the human breast milk. International Journal of Clinical Pharmacology 16: 579–580, 1978
Evaldson GR, Lindgren S, Nord CE, Rane AT. Tinidazole milk excretion and pharmacokinetics in lactating women. British Journal of Clinical Pharmacology 19: 503–507, 1985
Ferguson BB, Wilson DJ, Schaffner W. Determination of nicotine concentrations in human milk. American Journal of Diseases of Children 130: 837, 1976
Ferguson DM, Horwood LJ, Shannon FT, Taylor B. Parental smoking and lower respiratory illness in the first three years of life. Journal of Epidemiology and Community Health 35: 180–184, 1981
Fichter EG, Curtis JA. Sulphonamide administration in newborn and premature infants. American Journal of Diseases of Children 90: 596–597, 1955
Fidler J, Smith V, De Swiet M. Excretion of oxprenolol and timolol in breast milk. British Journal of Obstetrics and Gynaecology 90: 961–965, 1983
Fields JP. Bulging fontanel: a complication of tetracycline therapy in infants. Journal of Pediatrics 58: 74–76, 1961
Findlay JWA, Butz RF, Sailstead JM, Warren JT, Welch RM. Pseudoephedrine and triprolidine in plasma and breast milk of nursing mothers. British Journal of Clinical Pharmacology 18: 901–906, 1984
Findlay JWA, Deangelis RL, Kearney MF, Welch RM, Findlay JM. Analgesic drugs in breast milk and plasma. Clinical Pharmacology and Therapeutics 29: 625–633, 1981
Finley JP, Waxman MB, Wong PY, Lickrish GM. Digoxin excretion in human milk. Journal of Pediatrics 94: 339–340, 1979
Fleiss PM, Richwald J, Gordon J, Stern M, Frantz M, et al. Aztreonam in human serum and breast milk. British Journal of Clinical Pharmacology 19: 509–511, 1985
Fotherby K, Towobola D, Muggeridge J, Elder M. Norethisterone levels in maternal serum and milk after intramuscular injection of norethisterone oenanthate as a contraceptive. Contraception 28(5): 405, 1983
Franke G, Pietsch P, Schneider T, Seigmund W, Grabow D, et al. Studies on the kinetics and distribution of dihydralazine in pregnancy. Biological Research in Pregnancy 7: 30–33, 1986
Fried PA, Watkinson B, Willan A. Marijuana use during pregnancy and decreased length of gestation. American Journal of Obstetrics and Gynecology 150: 23–27, 1984
Froescher W, Eichelbaum M, Niesen M, Dietrich K, Rausch P. Carbamazepine levels in breast milk. Therapeutic Drug Monitoring 6: 226–271, 1984
Gabriel M, Witolla C, Albani M. Sleep and aminophylline treatment of apnea in premature infants. European Journal of Pediatrics 128: 145–150, 1978
Gelenberg AJ. Amoxapine, a new antidepressant, appears in human milk. Journal of Nervous and Mental Disease 167: 635–636, 1979
Giacoia GP, Catz CS. Drugs and pollutants in breast milk. Clinics in Perinatology 6: 181–196, 1979
Gray MS, Kane P, Squires S. Further observations on metronidazole (Flagyl). British Journal of Venereal Diseases 37: 278–279, 1961
Green TP, Mirkin BL. Clinical pharmacokinetics: paediatric considerations. In Benet et al. (Eds) Pharmacokinetic basis for drug treatment, pp. 269–282, Raven Press, New York, 1984
Guignard JP, Torrado A, Da Cunha O, Gautier E. Glomerular filtration rate in the first three weeks of life. Journal of Pediatrics, 87: 268–272, 1975
Guilbeau JA, Schoenbach EB, Schaub IG, Latham DV. Aureomycin in obstetrics: therapy and prophylaxis. Journal of the American Medical Association 143: 520–526, 1950
Hall B. Changing composition of human milk and early development of appetite control. Lancet 1: 779–781, 1975
Hardell LI, Lindstrom B, Lonnerholm G, Osterman PO. Pyridostigmine in human breast milk. British Journal of Clinical Pharmacology 14: 565–567, 1982
Harley JD, Robin H. ‘Late’ neonatal jaundice in infants with glucose 6-phosphate dehydrogenase-deficient erythrocytes. Australasian Annals of Medicine 11: 148–155, 1962
Harrison VC, Peat G. Significance of milk pH in new born infants. British Medical Journal 4: 515–518, 1972
Hartikainen-Sorri AL, Heikkinen JE, Koivisti M. Pharmacokinetics of clonidine during pregnancy and nursing. Obstetrics and Gynecology 69: 598–600, 1987
Heikkila M, Haukkamaa M, Luukkainen T. Levonorgestrel in milk and plasma of breast-feeding women with a levonorgestrel-releasing IUD. Contraception 25: 41–49, 1982
Heisterberg L, Branebjerg P. Blood and milk concentrations of metronidazole in mothers and infants. Journal of Perinatal Medicine 11: 114–120, 1983
Hersh JH, Podruch PE, Rogers G, Weisskopf B. Toluene embryopathy. Journal of Pediatrics 106: 922–977, 1985
Hilbert J, Gural R, Symchowicz S, Zampaglione N. Excretion of quazepam into human breast milk. Journal of Clinical Pharmacology 24: 457–462, 1984
Hill LM, Malkasian GD. The use of quinidine sulfate throughout pregnancy. Obstetrics and Gynecology 54: 366–368, 1979
Hingson R, Alpert JJ, Day N, Dooling E, Kayne H, et al. Effects of maternal drinking and marijuana use on fetal growth and development. Pediatrics 70: 539–546, 1982
Hofmeyr GJ, Iddekinge B, Blott JA. Domperidone: secretion in breast milk and effect on puerperal prolactin levels. British Journal of Obstetrics and Gynaecology 92: 141–144, 1985
Holdiness MR. Antituberculosis drugs and breast feeding. Archives of Internal Medicine 144: 1888, 1984
Holmberg PC. Central nervous system defects in children born to mothers exposed to organic solvents during pregnancy. Lancet 2: 177–179, 1979
Howell J, Clozel M, Aranda JV. Adverse effects of caffeine and theophylline in the newborn infant. Seminars of Perinatology 5: 359–369, 1981
Humpel M, Stopelli I, Milia S, Rainer E. Pharmacokinetics and biotransformation of the new benzodiazepine, lormetazepam, in man. European Journal of Clinical Pharmacology 21: 421–425, 1982
Hytten FE. Trends in milk composition during course of lactation. British Medical Journal 1: 249–253, 1954
Ilett K, Hackett L, Paterson J. Excretion of metrizamide in milk. British Journal of Radiology 54: 537–538, 1981
Inoue H, Unno N, Ou MC, Sugimoto T. Level of verapamil in human milk. European Journal of Clinical Pharmacology 26: 657, 1984
Iosub S, Fuchs M, Bingol N, Gromisch DS. Fetal alcohol syndrome revised. Pediatrics 68: 475–479, 1981
Jamali F, Stevens D. Naproxen excretion in milk and its uptake by the infant. Drug Intelligence and Clinical Pharmacy 17: 910–911, 1983
Jarnerot G. Into-Malmberg MB. Sulphasalazine treatment during breast feeding. Scandinavian Journal of Gastroenterology 14: 869–871, 1979
Johns D, Rutherford L, Leighton P, Vogel C. Secretion of methotrexate into human milk. American Journal of Obstetrics and Gynecology 112: 978–980, 1972
Jones HMR, Cummings AJ. A study of the transfer of α-methyldopa to the human foetus and newborn infant. British Journal of Clinical Pharmacology 6: 432–434, 1978
Jones KL, Smith DW, Ulleland CN, Streissguth AP. Pattern of malformation in offspring of chronic alcoholic women. Lancet 1: 1076–1078, 1973
Kafetzis DA, Brater DC, Fanourgakis JE, Voyatzis J, Georgakopoulos P. Ceftriaxone distribution between maternal blood and foetal blood and milk postpartum. Antimicrobial Chemotherapy 23: 870–873, 1983
Kafetzis DA, Lazarides CV, Siafas CA, Georgakopoulos PA, Papadotas CJ. Transfer of cefotazime in human milk and from mother to foetus. Journal of Antimicrobial Chemotherapy 6 (Suppl. A): 135–141, 1980
Kafetzis DA, Siafas PA, Georgakopoulos PA, Papadatos CJ. Passage of cephalosporins and amoxycillin into breast milk. Acta Paediatrica Scandinavica 70: 285–288, 1981
Kampmann J, Johansen K, Hansen J, Helweg J. Propylthiouracil in human milk. Lancet 1: 736–738, 1980
Kaneko S, Sato T, Suzu K. The levels of anticonvulsants in breast milk. British Journal of Clinical Pharmacology 7: 624–627, 1979
Katz F, Duncan B. Entry of prednisone into human milk. New England Journal of Medicine 293: 1154, 1975
Kaufman KR, Petrucha RA, Pitts FN, Weekes ME. PCP in amniotic fluid and breast milk: case report. Journal of Clinical Psychiatry 44: 269–270, 1983
Kauppila A, Arvela P, Koivisto M, Kivinen S, Ylikorkala O, et al. Metoclopramide and breast feeding: transfer into milk and the newborn. European Journal of Clinical Pharmacology 25: 819–823, 1983
Kelnar CJH, Harvey D. The sick newborn baby, p. 143, Bailliere Tindall, London, 1981
Kemp J, Illet KF, Booth J, Hackett LP. Excretion of doxepin and N-desmethyldoxepin in human milk. British Journal of Clinical Pharmacology 20: 497–499, 1985
Kesaneimi YA. Ethanol and acetaldehyde in the milk and peripheral blood of lactating women after ethanol administration. Journal of Obstetrics and Gynaecology of the British Commonwealth 81: 84–86, 1974
Khan AZA, Truelove SC. Placental and mammary transfer of sulphasalazine. British Medical Journal 2: 1553, 1979
Kirk L, Jorgenson A. Concentrations of CIS (Z)-flupentixol in maternal serum, amniotic fluid, umbilical cord serum and milk. Psychopharmacology 72: 107–108, 1980
Koetsawang S. Injected long-acting medroxyprogesterone acetate: effect on human milk and concentrations in milk. Journal of the Medical Association, Thailand 60: 57–60, 1977
Koetsawang S, Nukulkarn P, Fotherby K, Shrimanker AK, Mangalam M, et al. Transfer of contraceptive steroids in milk of women using long-acting gestagens. Contraception 25: 321–331, 1982
Kok TH, Taitz HG, Bennet MJ, Holt DW. Drowsiness due to clemastine transmitted in breast milk. Lancet 1: 914, 1982
Krause W, Stoppelli I, Milia S, Rainer E. Transfer of mepindolol to newborn by breast-feeding mothers after single and repeated daily doses. European Journal of Clinical Pharmacology 22: 53–55, 1982
Kuhnz W, Koch S, Jakob S, Hartman A, Helge H, et al. Ethosuximide in epileptic women during pregnancy and lactation period: placental transfer, serum concentrations in nursed infants and clinical status. British Journal of Clinical Pharmacology 18: 671–677, 1984
Kulas J, Lunell NO, Rosing U, Steen B, Rane A. Atenolol and metoprolol: a comparison of their excretion into human breast milk. Acta Obstetricia et Gynaecologica Scandinavica 118: 65–69, 1984
Lau RJ, Emery MG, Galinsky E. Unexpected accumulation of acyclovir in breast milk with estimation of infant exposure. Obstetrics and Gynaecology 69: 468–471, 1987
Leake RD, Trygstad CW, Oh W. Inulin clearance in the newborn infant: relationship to gestational and postnatal age. Pediatric Research 10: 759–762, 1976
Lentner C (Ed). Geigy scientific tables, 8th ed., vol. 1, p. 214, Ciba Geigy, Basle, 1984a
Lentner C (Ed). Geigy scientific tables, 8th ed., vol. 3, p. 140, Ciba Geigy, Basle, 1984b
Levitan A, Manion J. Propranolol therapy during pregnancy and lactation. American Journal of Cardiology 32: 247, 1973
Lewis P, Devenish C, Kahn C. Controlled trial of metoclopramide in the initiation of breast feeding. British Journal of Clinical Pharmacology 9: 217–219, 1980
Lewis A, Johnston A, Patel L, Turner P. Mexiletine in human blood and breast milk. Postgraduate Medical Journal 57: 546–547, 1981
Levine RL, Fredericks WR, Rapaport SI. Entry of bilirubin into the brain due to opening of the blood-brain barrier. Pediatrics 69: 225–259, 1982
Levy M, Granit L, Laufer N. Excretion of drugs in human milk. New England Journal of Medicine 297(14): 789, 1975
Liedholm H, Melander A, Bitzen PO, Helm G, Lonnerholm G, et al. Accumulation of atenolol and metoprolol in human breast milk. European Journal of Clinical Pharmacology 20: 229–231, 1981
Liedholm H, Wahlin-Boll E, Hanson A, Ingemarsson I, Melander A. Transplacental passage and breast milk concentrations of hydralazine. European Journal of Clinical Pharmacology 21: 417–419, 1982
Lindberg C, Boreus LO, De Chateau P, Lindstrom G, Nyberg L. Transfer of terbutaline into breast milk. European Journal of Respiratory Diseases 65 (Suppl. 134): 87–91, 1984
Liu DTY, Savage JM, Donnell D. Nefopam excretion in human milk. British Journal of Clinical Pharmacology 23: 99–101, 1987
Loggie JMH, Kleinman LI, Van Maanen EF. Renal function and diuretic therapy in infants and children. Part 1, Journal of Pediatrics 86: 485–496, 1985
Lonnerdal B, Forsum E, Hambraeus L. A longitudinal study of the protein, nitrogen and lactose contents of human milk from Swedish well-nourished mothers. American Journal of Clinical Nutrition 29: 1127–1133, 1976
Lonnerholm G, Lindstrom B. Terbutaline excretion into breast milk. British Journal of Clinical Pharmacology 13: 729–730, 1982
Lou MA, Wu YH, Jacob LS, Pitkin DH. Penetration of cefonicid into human breast milk and various body fluids and tissues. Reviews of Infectious Diseases 6(S4): S816–S820, 1984
Loughnan PM. Digoxin excretion in human breast milk. Journal of Pediatrics 92: 1019–1020, 1978
Low LCK, Lang J, Alexander WD. Excretion of carbimazole and propylthiouracil in breast milk. Lancet 2: 1011, 1979
Lucey JF. Bilirubin and brain damage: a real mess. Pediatrics 69: 381–382, 1982
Luck W, Nau H. Nicotine and cotinine concentrations in serum and milk of nursing smokers. British Journal of Clinical Pharmacology 18: 9–15, 1984
Luck W, Nau H. Nicotine and cotinine concentrations in serum and urine of infants exposed via passive smoking or milk from smoking mother. Journal of Pediatrics 107: 816–820, 1985
Lustgarten JS, Podos SM. Topical timolol and the nursing mother. Archives of Ophthalmology 101: 1381–1382, 1983
McCracken GH, Siegel JD. Clinical pharmacology of antimicrobial agents. In Remington & Klein (Eds) Infectious diseases of the fetus and newborn infant, pp. 1053–1096, WB Saunders, Philadelphia, 1983
McKenna WJ, Harris L, Rowland E, Whitelaw A, Storey G, et al. Amiodarone therapy during pregnancy. American Journal of Cardiology 51: 1231–1233, 1983
McKenzie S, Selley J, Agnew J. Secretion of prednisolone into breast milk. Archives of Disease in Childhood 50: 894–896, 1975
Maisels MJ. Neonate jaundice. In Avery (Ed.) Neonatology: pathophysiology and management of the newborn, 2nd ed., pp. 473–544, JB Lippincott Co, Philadelphia, 1981
Mannering GJ. Drug metabolism in the newborn. Federation Proceedings 44: 2302–2308, 1985
Matheson I, Evang A, Overo KF, Syverson G. Presence of chlorprothixene and its metabolites in breast milk. European Journal of Clinical Pharmacology 27: 611–613, 1984
Matsuda S. Transfer of antibiotics into maternal milk. Biological Research in Pregnancy 5: 57–60, 1984
Medina A, Fiske N, Hjelt-Harvey I, Brown CD, Prigot A. Absorption diffusion, and excretion of a new antibiotic, lincomycin. Antimicrobial Agents and Chemotherapy 3: 189–196, 1963
Michael CA. Use of labetalol in the treatment of severe hypertension during pregnancy. British Journal of Clinical Pharmacology 8: 211S–215S, 1979
Miles MV. Paediatric pharmacokinetics. In Mungall (Ed.) Applied clinical pharmacokinetics, pp. 367–388, Raven Press, New York, 1983
Miller GE, Peters RD, Engebretsen RV, Stowe CM. Passage of pentobarbital and phenobarbital into bovine and caprine milk after systemic administration. Journal of Dairy Science 50: 769–772, 1967
Miller R, Keegan K, Thrupp L, Brann J. Human breast milk concentration of moxalactam. American Journal of Obstetrics and Gynecology 148(3): 348–349, 1984
Miller MR, Withers R, Bhamra R, Holt DW. Verapamil and breast-feeding. European Journal of Clinical Pharmacology 30: 125–126, 1986
Mischler TW, Corson SL, Larranga A, Bolognese RJ, Neiss ES, et al. Cephradine and epicillin in body fluids of lactating and pregnant women. Journal of Reproductive Medicine 21: 130–136, 1978
Moiel RH, Ryan JR. Tolbutamide orinase in human breast milk. Clinical Paediatrics 6: 480, 1967
Moore B, Collier J. Drugs and breast feeding. British Medical Journal 2: 211, 1979
Morselli PL. Clinical pharmacokinetics in neonates. Clinical Pharmacokinetics 1: 81–98, 1976
Morselli PL, Franco-Morselli R, Bossi L. Clinical pharmacokinetics in newborns and infants: age-related differences and therapeutic implications. Clinical. Pharmacokinetics 5: 485–527, 1980
Mountford PJ, Coakley AJ. Guidelines for breastfeeding following maternal radiopharmaceutical administration. Nuclear Medicine Communications 7: 399–401, 1986
Mulley BA, Parr GD, Pau WK, Rye RM, Mould JJ, et al. Placental transfer of chlorthalidone and its elimination in maternal milk. European Journal of Clinical Pharmacology 13: 129–131, 1978
Nation RL, Hackett LP, Dusci LJ, Ilett KF. Excretion of hydroxychloroquine in human milk. British Journal of Clinical Pharmacology 17: 368–369, 1984
Neuvonen PJ. Interactions with the absorption of tetracyclines. Drugs 11: 45–54, 1976
Nilsson S, Nygren K-G, Johansson E. d-Norgestrel concentrations in maternal plasma, milk and child plasma during administration of oral contraceptives to nursing women. American Journal of Obstetrics and Gynaecology 129: 178, 1977
Nilsson S, Nygren K, Johansson EDB. Transfer of estradiol to human milk. American Journal of Obstetrics and Gynecology 132: 653–657, 1978
Notarianni LJ, Oldham HG, Bennett PN. Passage of paracetamol into breast milk and its subsequent metabolism by the neonate. British Journal of Clinical Pharmacology 24: 63–67, 1987
O’Brien TE. Excretion of drugs in human milk. American Journal of Hospital Pharmacy 31: 844–854, 1974
Ogunbona FA, Onye CO, Bolaji OO, Torimoro SEA. Excretion of chloroquine and desethylchloroquine in human milk. British Journal of Clinical Pharmacology 23: 473–476, 1987
Okada M, Inoue H, Nakamura Y, Kishimoto M. Excretion of diltiazem in human milk. New England Journal of Medicine 312: 992–993, 1958
Olsson B, Bolme P, Dahlstrom B, Marcus C. Excretion of noscapine in human breast milk. European Journal of Clinical Pharmacology 30: 213–215, 1986
Ost L, Wettrell G, Bjorkhem I, Rane A. Prednisolone excretion in human milk. Journal of Pediatrics 106: 1008–1011, 1985
Ostensen M. Piroxicam in human breast milk. European Journal of Clinical Pharmacology 25: 829–830, 1983
Ostensen M, Brown ND, Chiang PK, Aarbakke J. Hydroxychloroquine in human breast milk. European Journal of Clinical Pharmacology 28: 357, 1985
Ostensen M, Skavdal K, Myklebust G, Tomassen Y, Aarbakke J. Excretion of gold into human breast milk. European Journal of Clinical Pharmacology 31: 251–252, 1986
Pereira GR, Barbosa NMM. Controversies in neonatal nutrition. Paediatric Clinics of North America 33: 65–89, 1986
Perez-Reyes M, Wall ME. Presence of delta-9 tetrahydrocannabinol in human milk. New England Journal of Medicine 307: 819–820, 1982
Phelps D, Karim A. Spironolactone: relationship between concentrations of dethioacetylated metabolite in human serum and milk. Journal of Pharmaceutical Sciences 66: 1203, 1977
Pittard WB, O’Neal W. Amitriptyline excretion in human milk. Journal of Clinical Psychopharmacology 6: 383–384, 1986
Plomp TA, Thiery M, Maes RAA. The passage of thiamphenicol and chloramphenicol into human milk after single and repeated oral administration. Veterinary and Human Toxicology 25: 167–172, 1983
Pond SM, Kreek MJ, Tong TG, Raghunath J, Benowitz NL. Altered methadone pharmacokinetics in methadone-maintained pregnant women. Journal of Pharmacology and Experimental Therapeutics 233: 1–6, 1985
Postellon DC, Aronow R. Iodine in mothers milk. Journal of the American Medical Association 247: 463, 1982
Putter J, Held F. Quantitative studies on the occurrence of praziquantel in milk and plasma of lactating women. European Journal of Drug Metabolism and Pharmacokinetics 4: 193–198, 1979
Pynnonen S, Sillanpaa M. Carbamazepine and mothers milk. Lancet 1: 63, 1975
Rane A, Wilson JT. Clinical pharmacokinetics in infants and children. Clinical Pharmacokinetics 1: 2–24, 1976
Rasmussen F. Mammary excretion of sulphonamides. Acta Pharmacologica et Toxicologica 15: 139–148, 1958
Rasmussen F. Mammary excretion of benzylpenicillin, erythromycin and penethamate hydroiodide. Acta Pharmacologica et Toxicologica 16: 194–200, 1959
Rasmussen F. Mammary excretion of antipyrine, ethanol, and urea. Acta Veterinaria Scandinavica 2: 151–156, 1961
Rasmussen F. The mechanism of drug secretion into milk. In Gall (Ed.) Dietary lipids and postnatal development, pp. 231–245, Raven Press, New York, 1973
Rees JA, Glass RC, Sporne GA. Serum and breast milk concentrations of dothiepin. Practitioner 217: 686, 1976
Resman BH, Blumenthal P, Jusko WJ. Breast milk distribution in theobromine chocolate. Journal of Pediatrics 91: 477–480, 1977
Robertson DM, Paganell R, Dinwiddie R, Levinsky RJ. Milk antigen absorption in the preterm and term neonate. Archives of Disease in Childhood 57: 369–372, 1982
Rylance GW. Neonatal pharmacology. In Roberton (Ed.) A textbook of neonatology, pp. 223–238, Churchill Livingstone, Oxford, 1986
Rylance GW, Woods CG, Donnelly MC, Oliver JS, Alexander WD. Carbimazole and breast-feeding. Lancet 1: 928, 1987
Sagraves R, Waller ES, Goehrs HR. Tolmetin in breast milk. Drug Intelligence and Clinical Pharmacy 19: 55–56, 1985
Sande MA, Mandell GL. Antimicrobial agents (continued). In Gilman et al. (Eds) The pharmacological basis of therapeutics, 7th ed., pp. 1170–1198, Macmillan, New York, 1985
Sandstrom B. Metoprolol excretion into breast milk. British Journal of Clinical Pharmacology 9: 518–519, 1980
Sandstrom B, Lindeberg S, Lundborg P, Regardh CG. Disposition of the adrenergic blocker metoprolol in late pregnant women, the amniotic fluid, the cord blood and the neonate. Clinical and Experimental Hypertension B2: 75–82, 1983
Saxena B, Schrimanker K, Grudzinskas J. Levels of contraceptive steroids in breast milk and plasma of lactating women. Contraception 16: 605–613, 1977
Schanker LS. Passage of drugs across body membranes. Pharmacology Reviews 14: 501–530, 1962
Schou M, Amdisen A. Lithium and pregnancy: III. British Medical Journal 2: 138, 1973
Sereni F, Cislaghi GU, Gervasani A. Developmental pharmacology. In Davis & Dobbing (Eds) Scientific foundations of paediatrics, 2nd ed., pp. 1066–1078, Heinemann, London, 1981
Siegal SR, Oh W. Renal function as a marker of fetal maturation. Acta Paediatrica Scandinavica 65: 481–485, 1976
Silverman WA, Andersen DH, Blanc WA, Crozier DN. A difference in mortality rate in incidence of kernicterus among premature infants allotted to two prophylactic antibacterial regimes. Pediatrics 18: 614–625, 1956
Sioufi A, Hillion D, Lumbroso P, Wainer R, Olivier-Martin M, et al. Oxprenolol placental transfer, plasma concentrations in newborns and passage into breast milk. British Journal of Clinical Pharmacology 18: 453–456, 1984
Smith M, Livingstone I, Hooper W, Eadie M, Triggs E. Propranolol, propranolol glucuronide, and naphthoxylactic acid in breast milk and plasma. Therapeutic Drug Monitoring 5: 87–93, 1983
Soderman P, Hartvig P, Fagerlund C. Acetazolamide excretion into human breast milk. British Journal of Clinical Pharmacology 17: 599, 1984
Somogyi A, Gugler R. Cimetidine excretion into breast milk. British Journal of Clinical Pharmacology 7: 627–628, 1979
Soyka LF. Caffeine ingestion during pregnancy: in utero exposure and possible effects. Seminars in Perinatology 5: 305–309, 1981
Stahlman MT. Newborn intensive care: success or failure. Journal of Pediatrics 105: 162–167, 1984
Stancer HC, Reed KL. Desipramine and 2-hydroxydesipramine in human breast milk and the nursing infants serum. American Journal of Psychiatry 143: 1597–1600, 1986
Stec GP, Greenberger P, Ruo T, Henthorn T, Morita Y, et al. Kinetics of theophylline transfer to breast milk. Clinical Pharmacology and Therapeutics 28: 404–408, 1980
Steen B, Rane A. Clindamycin passage into human milk. British Journal of Clinical Pharmacology 13: 661–664, 1982
Steen B, Rane A, Lonnerholm G, Falk O, Elwin C, et al. Phenytoin excretion in human breast milk and plasma levels in nursed infants. Therapeutic Drug Monitoring 4: 331–334, 1982
Steiner E, Villen T, Hallberg M, Rane A. Amphetamine excretion in breast milk. European Journal of Clinical Pharmacology 27: 123–124, 1984
Stewart AL, Reynolds EOR, Lipscomb AP. Outcome for infants of very low birthweight: survey of world literature. Lancet 1: 1038–1041, 1981
Stewart RB, Karas B, Springer PK. Haloperidol excretion in human milk. American Journal of Psychiatry 137: 849–850, 1980
Stoehr G, Juhl R, Veals J, Symchowicz S, Gural R, et al. The excretion of rosaramicin in breast milk. Journal of Clinical Pharmacology 25: 89–94, 1985
Stopelli I, Rainer E, Humpell M. Transfer of cyproterone acetate to the milk of lactating women. Contraception 22: 485–493, 1980
Streissguth AP, Clarren SK, Jones KL. Natural history of the fetal alcohol syndrome: a 10 year follow-up of eleven patients. Lancet 2: 85–91, 1985
Summerfield RJ, Nielsen MS. Excretion of lorazepam into breast milk. British Journal of Anaesthesia 57: 1042–1043, 1985
Syverson GB, Ratjke SK. Drug distribution within human milk phases. Journal of Pharmaceutical Sciences 74(10): 1071–1074, 1985
Taylor B, Wadsworth J. Maternal smoking during pregnancy and lower respiratory tract illness in early life. Archives of Disease in Childhood 62: 786, 1987
Tegler L, Lindstrom B. Antithyroid drugs in milk. Lancet 2: 591, 1980
Thorley KJ, McAinsh J. Levels of the beta-blockers atenolol and propranolol in the breast milk of women treated for hypertension in pregnancy. Biopharmaceutics & Drug Disposition 4: 299–301, 1983
Timmis AD, Jackson G, Holt DW. Mexiletine for control of ventricular dysrhythmias in pregnancy. Lancet 2: 647–648, 1980
Townsend RJ, Benedetti TJ, Erickson SH, Cengiz C, Gillespie WR, et al. Excretion of ibuprofen into breast milk. American Journal of Obstetrics and Gynecology 149: 184–186, 1984
Traeger A, Peiker G. Excretion of nalidixic acid via mother’s milk. Archives of Toxicology (Suppl. 4): 388–390, 1980
Trundle JI, Skellern GG. Gas Chromatographic determination of nicotine in human breast milk. Journal of Clinical Hospital Pharmacy 8: 289–293, 1983
Tyrala EE, Dodson WE. Caffeine secretion into breast milk. Archives of Disease in Childhood 54: 787–800, 1979
Valdivieso A, Valdes G, Spiro TE, Westerman RL. Minoxidil in breast milk. Annals of Internal Medicine 102: 135, 1985
Van Der Molen HJ, Hart PG, Wijmenga HG. Studies with 4-14C-lynestrenol in normal and lactating women. Acta Endocrinologica 61: 255–274, 1969
Varsano I, Fischl J, Shochet SB. The excretion of orally ingested nitrofurantoin in human milk. Journal of Pediatrics 82: 886–887, 1973
Verbeeck RK, Ross SG, McKenna EA. Excretion of trazodone in breast milk. British Journal of Clinical Pharmacology 22: 367–370, 1986
Verstraete M. Clinical application of inhibitors of fibrinolysis. Drugs 29: 236–261, 1985
Von Unruh G, Froescher W, Hoffman F, Niessen M. Valproic acid in breast milk: how much is really there? Therapeutic Drug Monitoring 6: 272–276, 1984
Walker PC. Neonatal bilirubin toxicity: a review of kernicterus and the implications of drug-induced bilirubin displacement. Clinical Pharmacokinetics 13: 26–50, 1987
Werthmann M, Krees S. Quantitative excretion of senokot in human breast milk. Medical Annals of the District of Columbia 42: 4–5, 1973
Whalley LJ, Blain PG, Prime JK. Haloperidol secreted in breast milk. British Medical Journal 282: 1746–1747, 1981
White GJ, White MK. Breast-feeding and drugs in human milk. Veterinary and Human Toxicology 22 (Suppl. 1): 1–44, 1980
Wiernik PH, Duncan JH. Cyclophosphamide in human milk. Lancet 1: 912, 1971
Wijmenga H, Van Der Molen H. Studies with 4-14C-mestranol in lactating women. Acta Endocrinologica 61: 665–677, 1969
Williams RH, Kay GA, Jandorf BJ. Thiouracil: its absorption, distribution and excretion. Journal of Clinical Investigation 23: 613–627, 1944
Wilson JT. Drugs in breast milk. ADIS Press, New York, 1981
Wilson JT, Brown RD, Hinson JL, Dailey JW. Pharmacokinetic pitfalls in the estimation of the breast milk plasma ratio for drugs. Annual Reviews of Pharmacology and Toxicology 25: 667–689, 1985
Witter FR, Smith RV. The excretion of pentoxifylline and its metabolites into human breast milk. American Journal of Obstetrics and Gynecology 151: 1094–1097, 1985
Wright JT, Waterson EJ, Barrison IG, Lewis IG, MacRae KD, et al. Alcohol consumption, pregnancy, and low birthweight. Lancet 1: 663–665, 1983
Yaffe SJ, Juchau MR. Perinatal pharmacology. Annual Review of Pharmacology 14: 219–238, 1974
Yoshioka H, Kazuhiko C, Takimoto M, Maruyamam S, Shimizu T. Transfer of cefazolin into human miulk. Journal of Pediatrics 94: 151–152, 1979
Yu VYH. Annotation: effectiveness of neonatal intensive care policies. Australian Pediatric Journal 20: 85–87, 1984
Yurchak AM, Jusko WJ. Theophylline secretion into breast milk. Paediatrics 57: 518–520, 1976
Zeisler JA, Gaarder TD, Mesquita SA. Lidocaine excretion in breast milk. Drug Intelligence and Clinical Pharmacy 20: 691–693
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Atkinson, H.C., Begg, E.J. & Darlow, B.A. Drugs in Human Milk. Clin-Pharmacokinet 14, 217–240 (1988). https://doi.org/10.2165/00003088-198814040-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003088-198814040-00003